Associated Papers
Warfarin therapy is feasible in CYP2C9*3 homozygous patients.
Ablin J et al.
European Journal of Internal Medicine, 2004
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
Kirchheiner J et al.
Clinical Pharmacology and Therapeutics, 2002
Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
Taur SR et al.
Journal of Postgraduate Medicine, 0
Select a paper to view details